Share this article
Spread the word on social media
CME sues to block onshore perpetual futures after $5B in volume
CME Group filed suit against the Commodity Futures Trading Commission on Thursday, challenging the agency's decision to treat perpetual futures from Kalshi and Coinbase as futures rather than swaps.
The move follows Kalshi's claim of more than $5 billion in perp volume since launch and a roughly 9% slide in CME's share price after the CFTC approvals.
What happened: regulator approved perps, incumbent pushed back
The CFTC approved Kalshi's application to list perpetual, non-expiring futures — Kalshi has said those contracts will trade 24/7 — and the commission issued related approvals and guidance affecting Coinbase's activities that could allow such contracts to clear on regulated platforms, though clearing will depend on specific clearing arrangements and implementation.
CME argues these instruments are economically swaps and should be subject to swap rules, which include different reporting and margin regimes; the CFTC has reportedly characterized the lawsuit as an attempt to block innovation and emphasized the need to allow market innovation.
Why it matters: a structural challenge to clearing and market hours
Perpetual futures replicate a model that dominates crypto derivatives, where perps account for the majority of derivatives trading and trade around the clock, often with leverage up to 100x on some venues.
If perps scale on regulated U.S. venues, they could siphon volume from CME's core cash- and benchmark-linked futures, which routinely see billions of dollars in daily notional traded; even a 1% shift in market share would be material to exchange fee pools.
History shows exchanges resist disintermediation: electronic trading in the 2000s and the rise of off-exchange venues reshaped fees and clearing relationships over a decade, and this dispute could determine whether perpetuals become a new onshore plumbing or remain a niche product.
Bull case: incumbents adapt, regulated perps expand the market
Proponents argue regulation legitimizes perps, attracting institutional flow that crypto venues cannot capture; if Coinbase (COIN) or Nasdaq (NDAQ) builds custody and clearing links, onshore perps could bring new fee revenue measured in hundreds of millions annually.
CME (CME) itself could benefit by offering its own perp-style contracts under its rulebook, preserving clearing revenues while extending product reach beyond traditional weekly and monthly expiries.
Bear case: legal precedent and margin risk concentrate volatility
If a court agrees with CME and reclassifies perps as swaps, platforms like Kalshi would face stricter capital, reporting and clearing obligations, potentially choking off fast growth; that outcome would favor incumbents and could cost Coinbase (COIN) first-mover advantage.
Perps also amplify counterparty and liquidity risk, a point regulators cite: because they never expire and use continuous funding, a $1 billion move in underlying liquidity could cascade through leverage, stressing clearinghouses and triggering tighter margining across the industry.
What this means for investors: where to look and what to do
Short term, treat CME shares as exposed to regulatory headline risk; the stock moved about 9% after the approvals, and the litigation could produce weeks of volatility tied to filings and preliminary injunction motions, likely within the next 30-90 days.
- Watch CME (CME): If CME wins, incumbents regain protection; consider hedging exposure or trimming positions if legal risk is unmanaged.
- Watch Coinbase (COIN): If perps survive as futures, Coinbase could monetize a 24/7 derivatives franchise; monitor quarterly guidance for derivatives revenue and custody contracts.
- Watch Nasdaq (NDAQ) and Cboe (CBOE): These exchanges could either defend share or enter the market; strategic moves or partnerships would be a catalyst.
- Watch Robinhood (HOOD): Retail access to regulated perps would change order flow; a 1% shift in retail futures activity could move option and equity derivatives volumes materially.
We rate the situation neutral for now: it's a legal fight with tangible stakes, but the long-term direction depends on precedent and whether regulated clearing adapts. Investors should size positions for outcome risk, follow court filings closely, and reassess after any preliminary rulings, which could arrive within 90 days.
"The outcome will decide whether perpetuals become mainstream onshore or remain an offshore, lightly regulated product,"
Actionable takeaway: If you own CME, consider a partial hedge or set a 6-12 month review trigger tied to the court docket; if you want leveraged exposure to a new-growth scenario, accumulate COIN in tranches on weakness and watch filings for perps revenue disclosures.
